Peptide receptor radionuclide therapy after NETTER-1 clinical trial: what should not be left behind

Maccauro Marco, Capozza Antonella, Seregni Ettore

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)155-157
Number of pages3
JournalClinical and Translational Imaging
Volume7
Issue number3
DOIs
Publication statusPublished - Jun 1 2019

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Peptide receptor radionuclide therapy after NETTER-1 clinical trial : what should not be left behind. / Marco, Maccauro; Antonella, Capozza; Ettore, Seregni.

In: Clinical and Translational Imaging, Vol. 7, No. 3, 01.06.2019, p. 155-157.

Research output: Contribution to journalEditorial

@article{e08127cdd1de46978e13b1d1e7f96a80,
title = "Peptide receptor radionuclide therapy after NETTER-1 clinical trial: what should not be left behind",
author = "Maccauro Marco and Capozza Antonella and Seregni Ettore",
year = "2019",
month = "6",
day = "1",
doi = "10.1007/s40336-019-00327-2",
language = "English",
volume = "7",
pages = "155--157",
journal = "Clinical and Translational Imaging",
issn = "2281-5872",
publisher = "Springer-Verlag Italia s.r.l.",
number = "3",

}

TY - JOUR

T1 - Peptide receptor radionuclide therapy after NETTER-1 clinical trial

T2 - what should not be left behind

AU - Marco, Maccauro

AU - Antonella, Capozza

AU - Ettore, Seregni

PY - 2019/6/1

Y1 - 2019/6/1

UR - http://www.scopus.com/inward/record.url?scp=85066012832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066012832&partnerID=8YFLogxK

U2 - 10.1007/s40336-019-00327-2

DO - 10.1007/s40336-019-00327-2

M3 - Editorial

AN - SCOPUS:85066012832

VL - 7

SP - 155

EP - 157

JO - Clinical and Translational Imaging

JF - Clinical and Translational Imaging

SN - 2281-5872

IS - 3

ER -